Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd.（PHH）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PHH · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Park Ha Biological Technology Co., Ltd.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
近期内幕交易记录
PHH 高管卖出股份 · PHH 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Oct 4, 2018 | Bogansky Michael R SVP & CFO | Other | 13,074 | $144K | Form 4 |
| Oct 4, 2018 | STEIN KEVIN Director | Other | 5,467 | $60K | Form 4 |
| Oct 4, 2018 | PIZZI CHARLES P Director | Other | 28,053 | $309K | Form 4 |
| Oct 4, 2018 | Neuhauser James C Director | Other | 7,942 | $87K | Form 4 |
| Oct 4, 2018 | CROWL ROBERT B CEO · Director | Other | 88,238 | $971K | Form 4 |
| Oct 4, 2018 | Carlin Jane D Director | Other | 34,228 | $377K | Form 4 |
| May 22, 2018 | CROWL ROBERT B CEO · Director | Other | 9,599 | $103K | Form 4 |
| May 22, 2018 | Bogansky Michael R SVP & CFO | Other | 4,226 | $46K | Form 4 |
| Apr 2, 2018 | STEIN KEVIN Director | Sale | 825 | $9K | Form 4 |
| Feb 25, 2018 | CROWL ROBERT B CEO · Director | Other | 1,559 | $14K | Form 4 |
| Feb 25, 2018 | Bogansky Michael R SVP & CFO | Other | 314 | $3K | Form 4 |
| Jan 2, 2018 | STEIN KEVIN Director | Sale | 825 | $8K | Form 4 |
| Oct 2, 2017 | STEIN KEVIN Director | Sale | 825 | $12K | Form 4 |
| Sep 23, 2017 | CROWL ROBERT B CEO · Director | Other | 18,153 | $245K | Form 4 |
| Sep 11, 2017 | PIZZI CHARLES P Director | Sale | 8,844 | $126K | Form 4 |
| Jun 28, 2017 | Carlin Jane D Director | Award | 8,639 | — | Form 4 |
| Jun 28, 2017 | PIZZI CHARLES P Director | Award | 8,639 | — | Form 4 |
| Jun 28, 2017 | Neuhauser James C Director | Award | 7,942 | — | Form 4 |
| Jun 28, 2017 | STEIN KEVIN Director | Award | 7,942 | — | Form 4 |
| May 22, 2017 | Bogansky Michael R SVP & CFO | Other | 4,490 | $61K | Form 4 |
| May 22, 2017 | CROWL ROBERT B EVP & COO | Other | 10,043 | $137K | Form 4 |
| Feb 25, 2017 | CROWL ROBERT B EVP & CFO | Other | 1,182 | $15K | Form 4 |
| Feb 25, 2017 | Bogansky Michael R SVP & Controller | Other | 330 | $4K | Form 4 |
| Nov 21, 2016 | CROWL ROBERT B EVP & CFO | Other | 12,222 | $178K | Form 4 |
| Nov 18, 2016 | CROWL ROBERT B EVP & CFO | Other | 15,276.75 | $227K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PHH 内幕交易
PHH 内幕交易
Park Ha Biological Technology Co., Ltd.（PHH）内幕交易数据来源于公司内部人（包括PHH）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。PHH内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Park Ha Biological Technology Co., Ltd.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PHH 内幕交易 · 5个问题Park Ha Biological Technology Co., Ltd.（PHH）的内部人包括高管和董事，如PHH等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026